Integra LifeSciences Holdings Corporation (NASDAQ: IART) is a Healthcare company (Medical - Devices) with a market capitalization of $1.1B. The Maz Rating grades it against the other companies in its sector.
Integra LifeSciences Holdings Corporation's current Maz Rating and its five factor grades are for members: log in to see them.
At $13.55, Integra LifeSciences Holdings Corporation trades at 80.9x trailing earnings, 0.6x sales and 1.0x book value, with an EV/EBITDA of 12.0. Over the last twelve months it generated about $1.7B of revenue and $13M of net income. It runs a gross margin of 52.5%, an operating margin of 38.3% and a net margin of 0.8%. It shows return on equity of 1.2%, return on invested capital of 11.4% and a free cash flow yield of 6.8%. On the balance sheet: a debt-to-equity ratio of 1.88 and a current ratio of 3.62. Over the past 52 weeks the share price ranged from $8.70 to $20.49, with a beta of 1.28.
Integra LifeSciences Holdings Corporation does not currently pay a dividend.
28 Wall Street analyst ratings cover the stock: 12 Buy, 12 Hold and 4 Sell, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.